Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.144
Peer-review started: December 16, 2020
First decision: January 7, 2021
Revised: January 12, 2021
Accepted: February 12, 2021
Article in press: February 12, 2021
Published online: March 24, 2021
Although under-recognized, cancer survivors continue to be at an increased risk of death from cardiovascular complications post-remission or cure. This increased burden of cardiovascular disease results from the interplay of various factors. Adequate cardiovascular risk assessment and timely intervention through a multi-disciplinary approach in these patients plays a pivotal role in the prevention of cardiovascular morbidity and mortality. We discuss the shortcomings of using current risk prediction scores in cancer survivors and provide some insights into cardiovascular risk management relevant for primary care physicians, oncologists, and cardiologists alike.
Core Tip: Accurate assessment of cardiovascular risk in adult cancer survivors is important. Cancer survivors form a unique subset of a vulnerable population given their exposures to potential cardiotoxic therapies. The importance of common preventive cardiovascular strategies in the long-term outcomes of cancer survivors is understated in clinical practice.